House FDA drug reform bill may be more acceptable to patient groups, patient rep indicates.
Executive Summary
HOUSE FDA DRUG REFORM BILL POTENTIALLY MORE ACCEPTABLE TO PATIENT GROUPS than the Senate FDA reform legislation, AIDS Action Council representative Gary Rose indicated July 2. At a press conference organized with Public Citizen, representatives of the American Foundation for AIDS Research, AIDS Action Council, National Organization for Rare Disorders and National Council on Aging criticized the recently-filed committee report on Sen. Kassebaum's (R-Kan.) FDA reform proposal (S 1477).